Tian Yanli, Li Li, Yang Rongya
Medical School of Chinese PLA, The Chinese PLA General Hospital Beijing, China ; Department of Dermatology, The General Hospital of Beijing Military Command Beijing, China.
Department of Dermatology, The General Hospital of Beijing Military Command Beijing, China.
Int J Clin Exp Med. 2015 Feb 15;8(2):2350-6. eCollection 2015.
We attempted to comprehensively assess the possible association between p53 Arg72Pro polymorphism and the risk of basal cell carcinoma (BCC).
We performed a literature search of case-control association studies on p53 Arg72Pro polymorphism and BCC susceptibility in PubMed and EMBASE. 7 eligible studies were finally identified and their data were extracted for this meta-analysis. BCC risk was determined with the fixed effects model using a pooled odds ratio (OR).
Using distinct genetic models, we found that p53 Arg72Pro polymorphism was not associated with the overall risk of BCC. We observed a similar trend towards the association when performing subgroup analysis for Caucasians and Asians.
Our results suggest that presence of the common p53 Arg72Pro polymorphism may not play a role in the development of BCC. Larger studies are needed to better confirm the association.
我们试图全面评估p53基因72密码子精氨酸(Arg)突变为脯氨酸(Pro)的多态性与基底细胞癌(BCC)风险之间的可能关联。
我们在PubMed和EMBASE数据库中检索了关于p53基因Arg72Pro多态性与BCC易感性的病例对照关联研究。最终确定了7项符合条件的研究,并提取了它们的数据用于本次荟萃分析。使用固定效应模型和合并比值比(OR)来确定BCC风险。
采用不同的遗传模型,我们发现p53基因Arg72Pro多态性与BCC的总体风险无关。在对高加索人和亚洲人进行亚组分析时,我们观察到了类似的关联趋势。
我们的结果表明,常见的p53基因Arg72Pro多态性可能在BCC的发生中不起作用。需要更大规模的研究来更好地证实这种关联。